An orally bioavailable inhibitor of MEK1/2 (IC₅₀ = 12 nM) that inhibits ERK phosphorylation in various cancer cell lines (IC₅₀s ≥ 5 nM); efficacious in several xenograft tumor models in mice, including those bearing K-Ras or B-Raf mutations, as well as in clinical studies…